drugs MODERATE Updated 2026-10-14

BioSpectra, Inc. recalls Biospectra Tris/Tromethamine, USP, GMP, API Grade, Manufactu

See all recalls from BioSpectra, Inc. →

Recalled Product

Biospectra Tris/Tromethamine, USP, GMP, API Grade, Manufactured at 100 Majestic Way, Bangor, PA 18013, NDC 64173-101-25

Share this recall: Facebook X / Twitter WhatsApp Email

Hazard / Issue

Failed stability specifications

Issued by

FDA

Affected States: CA
Lot/Code Info: Lot#: TRIS -E04-0226-0016; Exp 2/29/28

✅ What Should You Do?

  1. 1Stop taking this medication and contact your doctor or pharmacist immediately.
  2. 2Do NOT flush medications down the drain — use an FDA-approved drug take-back program.
  3. 3Check the lot number on your bottle or packaging against the recalled lots listed above.
  4. 4Report adverse events to FDA MedWatch or call 1-800-FDA-1088.

Looking for a safe alternative?

Search Amazon for Biospectra Tris/Tromethamine, USP, GMP, →

If you were harmed by this recalled product, Top Class Actions lists active class action lawsuits and settlements that may apply to you.

View official government recall

Related drugs Recalls

Apothecary Pharma LLC recalls Apothecary NAD+ Injection 200 mg/mL, 6 mL Sterile Multi-Dose

2026-10-14 · Lack of Assurance of Sterility

K.C. Pharmaceuticals, Inc. recalls Sterile Eye Drops Redness Relief (Glycerin 0.25%, Naphazoli

2026-10-14 · Lack of Assurance of Sterility

Carolina Infusion, LLC recalls SERMORELIN ACETATE 1 MG/ML INJECTABLE, Packaged in single-us

2026-10-14 · Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.

Carolina Infusion, LLC recalls SEMAGLUTIDE 3 MG/ML INJECTABLE, 8 x 0.1 mL syringes, Carolin

2026-10-14 · Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.